Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

Thuy Tran(Yale Cancer Center), Lucia B. Jilaveanu(Yale University)

Cancers

March 2, 2021

10.3390/cancers13051049

Cited by 14

Related Papers

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

|The Lancet|2024|729

Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens

|Oncotarget|2015|64

CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells

|PLoS Biology|2024|30

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases

|Journal of Neuro-Oncology|2020|27

Vascular mimicry as a facilitator of melanoma brain metastasis

|Cellular and Molecular Life Sciences|2024|11